Caitlin Thomas Ravichandran, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Angelman Syndrome | 2 | 2021 | 136 | 0.850 |
Why?
|
Bipolar Disorder | 12 | 2019 | 5023 | 0.580 |
Why?
|
Phosphocreatine | 5 | 2016 | 270 | 0.440 |
Why?
|
Psychotic Disorders | 6 | 2018 | 3028 | 0.410 |
Why?
|
Schizophrenic Psychology | 3 | 2017 | 1677 | 0.380 |
Why?
|
Functional Laterality | 2 | 2017 | 2291 | 0.370 |
Why?
|
Williams Syndrome | 2 | 2024 | 187 | 0.370 |
Why?
|
Dietetics | 1 | 2008 | 35 | 0.330 |
Why?
|
Schizophrenia | 5 | 2018 | 6866 | 0.300 |
Why?
|
Energy Metabolism | 7 | 2019 | 2896 | 0.260 |
Why?
|
Magnetic Resonance Spectroscopy | 10 | 2016 | 3757 | 0.260 |
Why?
|
Hallucinations | 2 | 2018 | 359 | 0.220 |
Why?
|
Brain | 13 | 2023 | 26345 | 0.220 |
Why?
|
Phosphates | 2 | 2016 | 785 | 0.220 |
Why?
|
Ubiquinone | 2 | 2015 | 186 | 0.210 |
Why?
|
Hypertension | 1 | 2022 | 8431 | 0.210 |
Why?
|
Autistic Disorder | 4 | 2013 | 1164 | 0.210 |
Why?
|
Creatine Kinase | 2 | 2015 | 694 | 0.200 |
Why?
|
Anti-Anxiety Agents | 1 | 2024 | 390 | 0.200 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2716 | 0.190 |
Why?
|
Catatonia | 1 | 2023 | 157 | 0.190 |
Why?
|
Publishing | 1 | 2008 | 828 | 0.190 |
Why?
|
Tics | 1 | 2021 | 67 | 0.190 |
Why?
|
Adenosine Triphosphate | 3 | 2016 | 2022 | 0.190 |
Why?
|
Analysis of Variance | 2 | 2008 | 6370 | 0.190 |
Why?
|
Dissociative Disorders | 1 | 2022 | 230 | 0.180 |
Why?
|
Psychiatric Status Rating Scales | 6 | 2021 | 6028 | 0.180 |
Why?
|
Clozapine | 1 | 2023 | 498 | 0.180 |
Why?
|
Aspartic Acid | 2 | 2019 | 575 | 0.160 |
Why?
|
Depressive Disorder, Major | 5 | 2016 | 4606 | 0.160 |
Why?
|
Psychomotor Agitation | 1 | 2020 | 287 | 0.150 |
Why?
|
Olfactory Perception | 1 | 2018 | 53 | 0.150 |
Why?
|
Antidepressive Agents | 3 | 2015 | 2836 | 0.140 |
Why?
|
Touch Perception | 1 | 2018 | 115 | 0.140 |
Why?
|
Aging | 5 | 2019 | 8613 | 0.140 |
Why?
|
Delusions | 1 | 2018 | 300 | 0.130 |
Why?
|
Microglia | 1 | 2023 | 1248 | 0.130 |
Why?
|
Affect | 2 | 2013 | 1475 | 0.130 |
Why?
|
Oligodendroglia | 1 | 2018 | 519 | 0.130 |
Why?
|
Anxiety | 4 | 2024 | 4253 | 0.120 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2010 | 964 | 0.120 |
Why?
|
Temporal Lobe | 2 | 2013 | 1671 | 0.120 |
Why?
|
Magnetic Field Therapy | 1 | 2013 | 28 | 0.120 |
Why?
|
Models, Statistical | 1 | 2008 | 5113 | 0.120 |
Why?
|
Longitudinal Studies | 2 | 2011 | 13880 | 0.120 |
Why?
|
S-Adenosylmethionine | 1 | 2014 | 212 | 0.110 |
Why?
|
Cytidine | 1 | 2012 | 67 | 0.110 |
Why?
|
Naltrexone | 1 | 2014 | 305 | 0.110 |
Why?
|
Research Design | 1 | 2008 | 5959 | 0.110 |
Why?
|
Depressive Disorder | 2 | 2016 | 3743 | 0.110 |
Why?
|
Double-Blind Method | 8 | 2024 | 11985 | 0.100 |
Why?
|
Young Adult | 16 | 2023 | 56255 | 0.100 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2021 | 1442 | 0.100 |
Why?
|
Male | 36 | 2023 | 349022 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 9812 | 0.100 |
Why?
|
Organophosphorus Compounds | 1 | 2013 | 217 | 0.100 |
Why?
|
Humans | 47 | 2024 | 739398 | 0.100 |
Why?
|
Anxiety Disorders | 3 | 2024 | 2674 | 0.100 |
Why?
|
Cytidine Diphosphate Choline | 1 | 2011 | 30 | 0.100 |
Why?
|
Adult | 24 | 2023 | 213394 | 0.100 |
Why?
|
Overweight | 1 | 2022 | 2355 | 0.100 |
Why?
|
Garbage | 1 | 2009 | 3 | 0.090 |
Why?
|
Glutamic Acid | 2 | 2019 | 1168 | 0.090 |
Why?
|
Narcotic Antagonists | 1 | 2014 | 562 | 0.090 |
Why?
|
Refuse Disposal | 1 | 2009 | 30 | 0.090 |
Why?
|
Waste Management | 1 | 2009 | 19 | 0.090 |
Why?
|
Diffusion Tensor Imaging | 2 | 2010 | 2301 | 0.090 |
Why?
|
Nootropic Agents | 1 | 2011 | 160 | 0.090 |
Why?
|
Female | 31 | 2023 | 378853 | 0.090 |
Why?
|
Caregivers | 1 | 2021 | 2067 | 0.090 |
Why?
|
Communication | 1 | 2023 | 3722 | 0.090 |
Why?
|
Cerebral Cortex | 2 | 2019 | 5721 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2023 | 3908 | 0.080 |
Why?
|
Sertraline | 1 | 2009 | 206 | 0.080 |
Why?
|
Sleep Deprivation | 1 | 2014 | 831 | 0.080 |
Why?
|
Parents | 1 | 2021 | 3368 | 0.080 |
Why?
|
Cocaine-Related Disorders | 1 | 2011 | 459 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2018 | 1702 | 0.070 |
Why?
|
Cities | 1 | 2009 | 512 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2116 | 0.070 |
Why?
|
Child | 9 | 2023 | 77033 | 0.070 |
Why?
|
Phosphorus Isotopes | 3 | 2013 | 126 | 0.070 |
Why?
|
Executive Function | 1 | 2016 | 1356 | 0.070 |
Why?
|
Marijuana Abuse | 1 | 2011 | 402 | 0.070 |
Why?
|
Sleep | 2 | 2020 | 4596 | 0.070 |
Why?
|
Phospholipids | 1 | 2010 | 783 | 0.070 |
Why?
|
Antipsychotic Agents | 1 | 2019 | 3055 | 0.070 |
Why?
|
Prevalence | 1 | 2022 | 15153 | 0.060 |
Why?
|
Altitude | 1 | 2006 | 160 | 0.060 |
Why?
|
Evoked Potentials | 1 | 2011 | 1057 | 0.060 |
Why?
|
Middle Aged | 22 | 2023 | 212863 | 0.060 |
Why?
|
Sickness Impact Profile | 1 | 2006 | 305 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2022 | 4220 | 0.060 |
Why?
|
Suicide, Attempted | 1 | 2013 | 1213 | 0.060 |
Why?
|
Benzodiazepines | 1 | 2010 | 1099 | 0.060 |
Why?
|
Brain Mapping | 4 | 2013 | 6666 | 0.060 |
Why?
|
Gonadal Hormones | 1 | 2023 | 29 | 0.060 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2013 | 993 | 0.060 |
Why?
|
Buspirone | 1 | 2024 | 82 | 0.060 |
Why?
|
Adolescent | 12 | 2023 | 85405 | 0.060 |
Why?
|
Creatine | 2 | 2019 | 422 | 0.060 |
Why?
|
Cell Membrane | 1 | 2013 | 3747 | 0.060 |
Why?
|
Central Nervous System | 1 | 2010 | 1362 | 0.060 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2012 | 1338 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 15070 | 0.050 |
Why?
|
Lorazepam | 1 | 2023 | 146 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2019 | 15036 | 0.050 |
Why?
|
Hypnotics and Sedatives | 1 | 2010 | 1158 | 0.050 |
Why?
|
Neural Pathways | 2 | 2011 | 2976 | 0.050 |
Why?
|
Glutamine | 2 | 2019 | 574 | 0.050 |
Why?
|
Suicide | 1 | 2013 | 1469 | 0.050 |
Why?
|
Hospitalization | 2 | 2020 | 10208 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2024 | 76631 | 0.050 |
Why?
|
Linear Models | 2 | 2010 | 5948 | 0.050 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2013 | 1951 | 0.050 |
Why?
|
Obsessive Behavior | 1 | 2021 | 47 | 0.050 |
Why?
|
Nausea | 1 | 2024 | 656 | 0.050 |
Why?
|
Pilot Projects | 3 | 2022 | 8275 | 0.050 |
Why?
|
Trazodone | 1 | 2020 | 66 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15511 | 0.050 |
Why?
|
Obesity | 1 | 2022 | 12643 | 0.040 |
Why?
|
Policy | 1 | 2023 | 501 | 0.040 |
Why?
|
Clonidine | 1 | 2020 | 164 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2018 | 35326 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2016 | 21694 | 0.040 |
Why?
|
Lung Diseases | 1 | 2008 | 1879 | 0.040 |
Why?
|
Aged | 13 | 2019 | 162698 | 0.040 |
Why?
|
Psoriasis | 1 | 2006 | 888 | 0.040 |
Why?
|
Comorbidity | 3 | 2019 | 10362 | 0.030 |
Why?
|
Marital Status | 1 | 2018 | 435 | 0.030 |
Why?
|
Phosphorus | 1 | 2016 | 338 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 14740 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2010 | 2558 | 0.030 |
Why?
|
Myelin Sheath | 1 | 2018 | 664 | 0.030 |
Why?
|
Oxygen | 1 | 2006 | 4158 | 0.030 |
Why?
|
Melatonin | 1 | 2020 | 719 | 0.030 |
Why?
|
Child, Preschool | 4 | 2022 | 40802 | 0.030 |
Why?
|
Immune System | 1 | 2019 | 801 | 0.030 |
Why?
|
Glycerylphosphorylcholine | 1 | 2013 | 25 | 0.030 |
Why?
|
Phosphatidylethanolamines | 1 | 2013 | 138 | 0.030 |
Why?
|
Ethanolamines | 1 | 2013 | 158 | 0.030 |
Why?
|
Phosphorylcholine | 1 | 2013 | 162 | 0.030 |
Why?
|
Nucleotides | 1 | 2014 | 461 | 0.030 |
Why?
|
Electromagnetic Fields | 1 | 2013 | 298 | 0.030 |
Why?
|
Smoking | 1 | 2008 | 8960 | 0.030 |
Why?
|
India | 2 | 2009 | 2189 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2022 | 62693 | 0.020 |
Why?
|
Alprazolam | 1 | 2010 | 98 | 0.020 |
Why?
|
Clonazepam | 1 | 2010 | 137 | 0.020 |
Why?
|
GABA Modulators | 1 | 2010 | 107 | 0.020 |
Why?
|
Mitochondria | 1 | 2023 | 3522 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2013 | 8977 | 0.020 |
Why?
|
Emotions | 1 | 2022 | 2642 | 0.020 |
Why?
|
Psychometrics | 2 | 2012 | 2995 | 0.020 |
Why?
|
Educational Status | 1 | 2018 | 2514 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2012 | 812 | 0.020 |
Why?
|
Choline | 1 | 2010 | 488 | 0.020 |
Why?
|
Panic Disorder | 1 | 2012 | 617 | 0.020 |
Why?
|
Acoustic Stimulation | 1 | 2013 | 1216 | 0.020 |
Why?
|
Substance Abuse Detection | 1 | 2011 | 283 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2015 | 2032 | 0.020 |
Why?
|
Self Report | 1 | 2019 | 3524 | 0.020 |
Why?
|
Organ Size | 1 | 2013 | 2247 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2019 | 38942 | 0.020 |
Why?
|
Heart Rate | 2 | 2011 | 4095 | 0.020 |
Why?
|
Psychotherapy, Group | 1 | 2011 | 406 | 0.020 |
Why?
|
Anisotropy | 1 | 2010 | 1265 | 0.020 |
Why?
|
Internet | 1 | 2019 | 3048 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2614 | 0.020 |
Why?
|
Education | 1 | 2009 | 543 | 0.020 |
Why?
|
Polysomnography | 1 | 2013 | 1765 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 3909 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18349 | 0.020 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2011 | 629 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2881 | 0.020 |
Why?
|
Cues | 1 | 2011 | 865 | 0.020 |
Why?
|
Mitochondrial Diseases | 1 | 2009 | 319 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2010 | 2030 | 0.020 |
Why?
|
Protons | 1 | 2010 | 1124 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 53037 | 0.020 |
Why?
|
Quality of Life | 1 | 2006 | 12640 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2010 | 1127 | 0.020 |
Why?
|
Cell Line | 1 | 2018 | 15987 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2016 | 57650 | 0.010 |
Why?
|
Suicidal Ideation | 1 | 2013 | 1236 | 0.010 |
Why?
|
Homeostasis | 1 | 2014 | 3348 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2012 | 19811 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 6963 | 0.010 |
Why?
|
Oximetry | 1 | 2006 | 465 | 0.010 |
Why?
|
Primary Health Care | 1 | 2019 | 4537 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4426 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6478 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29002 | 0.010 |
Why?
|
Language | 1 | 2010 | 1447 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2018 | 11460 | 0.010 |
Why?
|
Attention | 1 | 2011 | 2400 | 0.010 |
Why?
|
Risk Factors | 2 | 2020 | 71974 | 0.010 |
Why?
|
Respiration | 1 | 2006 | 1650 | 0.010 |
Why?
|
Electroencephalography | 1 | 2014 | 6133 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10534 | 0.010 |
Why?
|
Depression | 1 | 2019 | 7689 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4983 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8605 | 0.010 |
Why?
|
Time Factors | 2 | 2010 | 40050 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81002 | 0.010 |
Why?
|
Regression Analysis | 1 | 2006 | 6452 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 24714 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168368 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9133 | 0.010 |
Why?
|
Prognosis | 1 | 2011 | 28901 | 0.010 |
Why?
|
Infant | 1 | 2006 | 34923 | 0.000 |
Why?
|